The Road to MDD and PPD Remission: A Look at Novel Treatments for Episodic and Chronic Depression

Friday, June 2, 2023

11:15 AM – 12:15 PM PT

Location: Octavius 11

This Master Class session aims to equip healthcare professionals with the knowledge and skills to differentiate between episodic and chronic depression, assess the limitations of traditional antidepressant therapies in the management of MDD and PPD, as well as evaluate the efficacy and safety data for novel GABA-targeted therapies. Expert faculty will explore the latest developments in GABA-targeted therapies for the treatment of MDD and PPD as well as provide practical guidance on implementing these therapies in clinical practice.

Supported by an independent educational grant from Sage Therapeutics, Inc. and Biogen Inc.

Speaker(s)

GM

Gregory Mattingly, MD

Associate Clinical Professor
Washington University
Washington University School of Medicine
St Louis, Missouri
CM

Chelsie Monroe, APN, PMHNP-BC

Founder, Advanced Practice Nurse
Balanced Mental Wellness
University of Colorado Anschutz Medical Campus
Littleton, Colorado

Moderator(s)

Craig Chepke, MD, DFAPA

Medical Director, Excel Psychiatric Associates; Adjunct Associate Professor of Psychiatry, Atrium Health
Excel Psychiatric Associates
Huntersville, North Carolina